- Joined
- Oct 10, 2011
- Messages
- 9,017
- Reaction score
- 11,527
- Points
- 8,831
- Attending Physician
Advertisement - Members don't see this ad
What commonly prescribed targeted agents are people OK treating, with brain radiation (separate categories if necessary for WBRT and SRS) while the patient continues that drug for systemic disease? Main question would be in regards to safety (no increased toxicity profiles). I'm focusing more on targeted agents/IT (rather than cytotoxic chemotherapy) but if there's any chemotherapeutic agents you'd be comfortable treating SRS and/or WBRT I'm all ears.
I know we had a discussion about Ipi/Nivo and safety of SRS in Melanoma patients, but what about other disease sites and systemic treatments?
EGFR inhibitors (Tarceva, Tagrisso, Afatinib, etc.) - OK with SRS? OK with WBRT?
ALK inhibitors (Crizotinib, Alectinib) - OK with SRS? WBRT?
Immunotherapy (Pembro, Nivo say in a NSCLC, Atezolizumab, etc.) - OK with SRS? WBRT? Dependent on histology?
I'm interested in anecdotal tales as well as studies people may know of.
I know we had a discussion about Ipi/Nivo and safety of SRS in Melanoma patients, but what about other disease sites and systemic treatments?
EGFR inhibitors (Tarceva, Tagrisso, Afatinib, etc.) - OK with SRS? OK with WBRT?
ALK inhibitors (Crizotinib, Alectinib) - OK with SRS? WBRT?
Immunotherapy (Pembro, Nivo say in a NSCLC, Atezolizumab, etc.) - OK with SRS? WBRT? Dependent on histology?
I'm interested in anecdotal tales as well as studies people may know of.